Alkermes (ALKS) Current Taxes (2015 - 2016)
Alkermes' (ALKS) quarterly Current Taxes came in at $899000.0 in Q4 2016, down 24.77% year-on-year from $1.2 million in Q1 2016, and up 17.36% on a QoQ basis from $766000.0 in Q3 2016.
Alkermes (ALKS) Current Taxes (2015 - 2016) Analysis & Trends
Alkermes (ALKS) has 2 years of Current Taxes data on file, last reported at $899000.0 in Q4 2016.
- On a quarterly basis, Current Taxes fell 24.77% year-over-year to $899000.0 in Q4 2016; TTM through Dec 2016 was $899000.0, a 24.77% decrease from a year earlier, with the FY2016 full-year figure at $899000.0, down 24.77% from the prior year.
- Current Taxes for Q4 2016 stood at $899000.0, up from $766000.0 in the prior quarter.
- Over the last five years, Current Taxes for ALKS reached as high as $20.6 million in Q1 2016 and fell as low as $766000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 899,000.00 |
| Sep 30, 2016 | 766,000.00 |
| Jun 30, 2016 | 1.06 Mn |
| Mar 31, 2016 | 20.63 Mn |
| Dec 31, 2015 | 1.20 Mn |